Peptide stability is a measurement problem, not a freezer setting

A dry peptide vial can look unchanged for months. That observation is reassuring only in the narrowest sense: it describes appearance. It cannot tell a laboratory whether the original molecule remains intact, whether related compounds have formed, or whether particles will appear when the material enters solution. Stability is a measured property of a particular peptide and formulation in a particular container over time.

For research-use materials, the useful question is therefore not “What temperature works for peptides?” but “What evidence supports this material’s stated storage conditions?” Published studies offer a way to ask that question without treating one molecule’s result as a rule for all others.

1. Freeze-dried does not mean chemically frozen

Lyophilization removes much of the water from a frozen solution, leaving a solid that still has its own chemistry. Residual moisture, the starting solution, and any bulking agent can affect reactions within the dried cake. In one factorial study of a lyophilized aspartate-containing hexapeptide, moisture, temperature, and especially the choice of bulking agent changed solid-state reactivity. A companion study on a closely related asparagine-containing hexapeptide found that the pH of the solution before freeze-drying had the stronger effect on deamidation; the measured effects of temperature and moisture were smaller and interacted with that starting pH.^[2][3]

That comparison is the important lesson. Even two short model sequences did not rank the same stability variables in the same order. A peptide’s sequence, salt form, excipients, processing, and package all matter. Neither experiment establishes a universal expiration period for a vial purchased elsewhere.

2. Moisture is a formulation variable

A freeze-dried cake is exposed to a different environment once its container is opened or its seal fails. In a study of the CSP7 research peptide, lyophilized formulations held at 5 °C and protected from moisture were stable for up to ten months under the investigators’ conditions. When the same research program exposed cakes to 75% relative humidity, they absorbed water; excipient crystallization and reversible peptide aggregation followed.^[4] This is a controlled stress experiment, not a prediction of what will happen to every peptide in ordinary lab air.

The implication for a lab record is practical: note whether stability data concern unopened, sealed vials or material repeatedly exposed during sampling. Treat a claim about the dry material as a claim about its tested package and moisture history. “Drier is always better” is also too simple: the aspartate and asparagine studies show that water’s effect depends on the particular chemical system.^[2][3]

3. Temperature needs a time axis

A storage temperature has meaning only with a duration and a measured acceptance criterion. The ICH Q1A(R2) guideline describes stability testing of new drug substances and products as evidence of how quality changes with time under temperature, humidity, and light. It calls for studies in the proposed container closure and, where relevant, examination of short excursions during shipment or handling.^[1] The guideline governs pharmaceutical submissions; it is a useful evidence framework here, not a certification of any research-use product.

Notice what a single study cannot do. The CSP7 researchers reported results at specific temperatures, humidity exposures, and formulations. Their ten-month observation at 5 °C does not supply a ten-month claim for a different sequence, a different counter-ion, or even a different CSP7 formulation.^[4] Likewise, a brief shipping excursion cannot be judged from a steady-state storage label alone. Its effect must be evaluated against the relevant material and duration, ideally with a stability-indicating method rather than appearance alone.

4. Solution starts a different stability study

Moving a peptide into solution changes the reactions available to it. An exenatide study tracked chemical and physical degradation across solution pH values at 37 °C. Oxidation dominated at pH 5.5–6.5; deamidation dominated at pH 7.5–8.5, where the investigators also detected substantial aggregation. Those are experimental observations for exenatide at a specified test temperature, not a recipe or storage window for other peptides.^[5]

Freeze–thaw behavior is similarly specific. The CSP7 formulation tolerated at least five cycles in that investigation, showing that a cycle is not automatically destructive. It does not show that repeated cycles are safe for an untested material.^[4] Another study found that some lyophilized teriparatide formulations precipitated two to four weeks after being placed in solution, while comparable samples that had never been lyophilized showed no precipitation for up to twelve weeks. The investigators attributed this difference to structural changes during freezing and drying.^[6]

For bench work, a stated period for a dry sealed vial should never be silently carried over to a solution. The ICH framework explicitly treats stability after constitution or dilution as a separate question when applicable.^[1]

5. Read a storage claim like a dataset

A release Certificate of Analysis is a snapshot of a lot at testing. It may establish identity and initial purity, but those numbers alone cannot show how a peptide changes over weeks or months. A defensible storage claim names the material, formulation, container, conditions, time points, analytical methods, and acceptance criteria. Chemical assays and tests for physical change may answer different questions, as the exenatide and teriparatide studies illustrate.^[5][6]

Evidence checklist for research planning

• Does the evidence identify the exact peptide form, excipients, and container closure?
• Are temperature, humidity exposure, and elapsed time stated together?
• Were both the amount of intact peptide and relevant degradation or physical changes assessed?
• Does the result cover the material’s actual state: sealed dry solid, opened solid, or solution?
• Is any claimed period supported by time-point data, rather than only a release COA or an unrelated publication?

If one of these details is missing, record the uncertainty rather than extending another peptide’s result. For a research-use sample, the most useful storage guidance is the guidance that can be traced to evidence for that sample and its intended laboratory workflow.

Related reading: How to read a Certificate of Analysis and Why sterility and endotoxin results are different.